Literature DB >> 10687935

Morphological changes induced by administration of a Na+,K+-ATPase inhibitor in normal and hydropic inner ears of the guinea pig.

M Hamada1, R S Kimura.   

Abstract

The objective of this study was to determine the effects of ouabain, a Na+,K+-ATPase inhibitor, in inner ears. Administering ouabain locally through the round window and vestibule, resulted in degenerative changes in cochlear and vestibular sensory cells and limbal fibrocytes, but the stria vascularis and spiral ligament were less affected. The position of Reissner's membrane was rarely changed. Vacuolar spaces in the sensory epithelia of cristae, maccula utriculi and macula sacculi increased in number. Nystagmus was a common occurrence with or without demonstrating degeneration of vestibular sensory cells. By administering ouabain systemically, the course of developing endolymphatic hydrops could not be altered in the ears with endolymphatic duct blockage. Edema of nerve endings of inner hair cells and vestibular sensory cells was frequently observed with administration of a high concentration of ouabain in both normal and hydropic ears, but edema was reversible. Degeneration of some vestibular sensory cells were observed in hydropic ears with a long survival time. The mechanism of selective sensitivity or non-sensitivity of inner ear tissues to ouabain is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10687935     DOI: 10.1080/00016489950180423

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Reinnervation of hair cells by auditory neurons after selective removal of spiral ganglion neurons.

Authors:  Rodrigo Martinez-Monedero; C Eduardo Corrales; Math P Cuajungco; Stefan Heller; Albert S B Edge
Journal:  J Neurobiol       Date:  2006-03

2.  Ouabain-induced cochlear degeneration in rat.

Authors:  Yong Fu; Dalian Ding; Haiyan Jiang; Richard Salvi
Journal:  Neurotox Res       Date:  2012-04-03       Impact factor: 3.911

3.  Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis.

Authors:  R A Schmiedt; H-O Okamura; H Lang; B A Schulte
Journal:  J Assoc Res Otolaryngol       Date:  2001-12-20

Review 4.  Endogenous ouabain in renal Na(+) handling and related diseases.

Authors:  Paolo Manunta; Elisabetta Messaggio; Nunzia Casamassima; Guido Gatti; Simona Delli Carpini; Laura Zagato; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-11

5.  Contributions of Mouse and Human Hematopoietic Cells to Remodeling of the Adult Auditory Nerve After Neuron Loss.

Authors:  Hainan Lang; Eishi Nishimoto; Yazhi Xing; LaShardai N Brown; Kenyaria V Noble; Jeremy L Barth; Amanda C LaRue; Kiyoshi Ando; Bradley A Schulte
Journal:  Mol Ther       Date:  2016-09-07       Impact factor: 11.454

6.  Ouabain Does Not Induce Selective Spiral Ganglion Cell Degeneration in Guinea Pigs.

Authors:  Timo Schomann; Dyan Ramekers; John C M J de Groot; Carola H van der Ploeg; Ferry G J Hendriksen; Stefan Böhringer; Sjaak F L Klis; Johan H M Frijns; Margriet A Huisman
Journal:  Biomed Res Int       Date:  2018-07-31       Impact factor: 3.411

Review 7.  Experimental animal models of drug-induced sensorineural hearing loss: a narrative review.

Authors:  Xuexin Lin; Jia Luo; Jingqian Tan; Luoying Yang; Mitian Wang; Peng Li
Journal:  Ann Transl Med       Date:  2021-09

8.  Ouabain-induced apoptosis in cochlear hair cells and spiral ganglion neurons in vitro.

Authors:  Yong Fu; Dalian Ding; Lei Wei; Haiyan Jiang; Richard Salvi
Journal:  Biomed Res Int       Date:  2013-10-22       Impact factor: 3.411

9.  Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration.

Authors:  Sandra Hackelberg; Samuel J Tuck; Long He; Arjun Rastogi; Christina White; Liqian Liu; Diane M Prieskorn; Ryan J Miller; Che Chan; Benjamin R Loomis; Joseph M Corey; Josef M Miller; R Keith Duncan
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.